StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.15−0.10 (-8.00%)

Close on Nov 18, 2026Market cap $82.37MP/E –Yield 0.00%

Nkarta operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nkarta's operating cash flow for the twelve months ending Jun 30, 2026 was -$92.76M. For fiscal 2025 it was -$88.70M. The highest annual figure on record is -$18.37M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$88.70M–
FY2024Dec 31, 2024-$99.70M–
FY2023Dec 31, 2023-$86.16M–
FY2022Dec 31, 2022-$57.00M–
FY2021Dec 31, 2021-$67.93M–
FY2020Dec 31, 2020-$43.51M–
FY2019Dec 31, 2019-$18.37M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$24.22M–
Q1 FY2026Mar 31, 2026-$28.20M–
Q4 FY2025Dec 31, 2025-$21.65M–
Q3 FY2025Sep 30, 2025-$18.69M–
Q2 FY2025Jun 30, 2025-$18.75M–
Q1 FY2025Mar 31, 2025-$29.61M–
Q4 FY2024Dec 31, 2024-$24.75M–
Q3 FY2024Sep 30, 2024-$24.55M–
Q2 FY2024Jun 30, 2024-$21.89M–
Q1 FY2024Mar 31, 2024-$28.51M–
Q4 FY2023Dec 31, 2023-$23.35M–
Q3 FY2023Sep 30, 2023-$20.28M–
Q2 FY2023Jun 30, 2023-$21.77M–
Q1 FY2023Mar 31, 2023-$20.76M–
Q4 FY2022Dec 31, 2022-$7.33M–
Q3 FY2022Sep 30, 2022-$14.80M–
Q2 FY2022Jun 30, 2022-$16.61M–
Q1 FY2022Mar 31, 2022-$18.26M–
Q4 FY2021Dec 31, 2021-$17.57M–
Q3 FY2021Sep 30, 2021-$18.26M–
Q2 FY2021Jun 30, 2021-$17.45M–
Q1 FY2021Mar 31, 2021-$14.65M–
Q4 FY2020Dec 31, 2020-$12.85M–
Q3 FY2020Sep 30, 2020-$12.12M–
Q2 FY2020Jun 30, 2020-$10.24M–
Q1 FY2020Mar 31, 2020-$8.29M–
Q4 FY2019Dec 31, 2019-$6.64M–
Q3 FY2019Sep 30, 2019-$4.65M–

More Nkarta figures

See a number that looks wrong?